Article

Musty Odor Reason behind another Tylenol Recall

Author(s):

McNeil, producer of over-the-counter drugs like Tylenol and Benadryl, has issued yet another recall due to a musty odor associated with packaging.

The most recent in a series of over-the-counter drug recalls is now Tylenol 8-hour caplets 50 count. Numerous complaints about the odor of these particular packages, which are sold in the United States and Puerto Rico, are what led to the recall by McNeil, despite the company saying that “the risk of adverse medical events is remote.”

An estimated 128,000 bottles will be recalled, the lot of which was made in March at a factory in Fort Washington, Pennsylvania. The most recent recall for McNeil adds to a laundry list of recalls that have added up to tens of millions of bottles, all within the past year. Because of the numerous recalls, McNeil now faces a US congressional probe of quality control lapses.

Reuters reports that the FDA “cited thick dust, grime and contaminated ingredients at the Fort Washington plant. J&J plans to reopen the plant next year, and is using other McNeil plants to help offset lost production of the recalled products.”

Although a recall is obviously never a good thing for a company, this is an especially bad time for McNeil, as the company is scheduled to report third quarter earnings today.

Around the Web

Musty odor sparks another Tylenol recall [Reuters]

More Trouble With Tylenol [NY Times]

That Familiar Musty Odor Hits J&J Again [WSJ]

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
4 experts are featured in this series.
© 2024 MJH Life Sciences

All rights reserved.